Razagilin Stada 1 mg tablete
| Name | Razagilin Stada 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-123204257 |
| Active Substance | razagilintartarat |
| Composition | jedna tableta sadrži 1 mg razagilina (u obliku tartarata) |
| Pharmaceutical Form | tableta |
| Manufacturer | STADA Arzneimittel AG, Bad Vilbel, Njemačka STADA Arzneimittel GmbH, Beč, Austrija Clonmel Healthcare Ltd., Clonmel, Co. Tipperary, Irska Centrafarm Services B.V., Breda, Nizozemska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 16.07.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/54 |
| Registration Number | 381-12-01/30-20-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BD02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
